Extract

Eligible patients with Psoriasis will be treated with CF101 or placebo twice daily for 16 weeks. All subjects will receive open-lable CF101 in weeks 17-32.

Inclusion criteria

• Plaque psoriasis

Country

• Bulgaria
• Israel
• Romania
• United States

Links

• ictrp
• nct